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Key message
Antenatal bladder drainage appears to improve perinatal survival in cases of congenital LUTO.
Short tles
Antenatal intervenon for congenital LUTO.
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ABSTRACT
Objective: To evaluate the effectiveness of antenatal intervention for the treatment of congenital lower
urinary tract obstruction (LUTO) in improving perinatal survival and postnatal renal function.
Methods: Electronic databases were searched from their incepon unl May 2018. Selecon
criteria included randomized controlled trials and controlled non-randomized observaonal studies
including fetuses with ultrasound evidence of LUTO evaluang antenatal intervenon for improving
perinatal outcomes. Any type of intervenon was analyzed. The primary outcome was perinatal
survival. The secondary outcome was postnatal survival with normal renal funcon. The summary
measures were reported as summary odds rao (OR) with 95% of conﬁdence interval (CI).
Results: 10 articles with a total of 355 fetuses were included in the meta-analysis. Inclusion criteria
of the selected studies were singleton pregnancy with severe LUTO confirmed on detailed fetal
ultrasound examination. Nine studies,analyzed the efficacy of vescico-amniotic shunt performed in
the second trimester. The overall estimate survival was higher in the vesico-amniotic shunt group
compared to the conservative group (OR 2.54, 95% CI 1.14 to 5.67). 64/112 fetuses (57.1%) survived
in the vescico-amniotic shunt group compared to 52/134 (38.8%) in the control group. Five studies
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reported on postnatal renal function between 6 months and 2 years. Postnatal renal function was higher
in the vescico-amniotic shunt group compared to the conservative group (OR 2.09, 95% CI 0.74 to
5.9). Fetal cystoscopy was performed in only two included studies.Overall, 45 fetuses underwent fetal
cystoscopy. The perinatal survival was higher in the cystoscopy group compared to the conservative
management group (OR 2.63, 95% CI 1.07 to 6.47). Normal renal function was noted in 13/34 fetuses
in the cystoscopy group versus 12/61 in the conservative management group at 6 month follow-up
(OR 1.75, 95% CI 1.05 to 2.92)
Conclusions: Antenatal bladder drainage appears to improve perinatal survival in cases of LUTO.
Further randomized trials with long-term follow-up are required to determine the role of antenatal
treatment in clinical setting.
INTRODUCTION
Congenital lower urinary tract (bladder neck) obstruction (LUTO) comprises a heterogeneous group
of conditions, including congenital posterior urethral valves (PUV) and urethral atresia.1 They are the
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leading cause of pediatric end-stage kidney disease,2 and have been associated with a mortality rate
as high as 45%.1
The accuracy of antenatal ultrasound for detection of the condition has been improved in the last
years.3 LUTO in a male fetus presenting with megacystis in the first or second trimester of pregnancy
is as likely to reflect urethral atresia or stenosis as it is PUV.3
Although postnatal correction of LUTO relieves the urinary obstruction, it is usually too late to
rescue the renal and respiratory consequences.4-6 Several antenatal techniques have been studied in
attempts to improve the outcomes of the condition. The most common antenatal treatment are serial
ultrasound-directed vesicocentesis, vescico-amniotic shunting, fetal cystoscopy and valve ablation.1
Some authors have also been reported cases describing open surgical correction.1
The aim of this systematic review was to evaluate the effectiveness of antenatal intervention for the
treatment of LUTO in improving perinatal survival and postnatal renal function.
METHODS
Search strategy
This review was performed according to a protocol designed a priori and recommended for
systemac review.7Electronic databases (i.e. MEDLINE, Scopus, ClinicalTrials.gov, EMBASE,
Sciencedirect, the Cochrane Library at the CENTRAL Register of Controlled Trials, Scielo) were
searched from their incepon unl May 2018. Search terms used were the following text words:
urethral obstrucon, prune belly syndrome, enlarged bladder, congenital urinary tract obstrucon,
LUTO, posterior valves, fetal therapies, fetal cystoscopy, and vescico-amnioc shunt. No restricons
for language or geographic locaon were applied. In addion, the reference lists of all idenﬁed
arcles were examined to idenfy studies not captured by electronic searches. The electronic
search and the eligibility of the studies were independently assessed by two authors (GS, ER).
Diﬀerences were discussed and consensus reached.
Selection criteria
Selection criteria included randomized controlled trials and controlled non-randomized observational
studies including fetuses with ultrasound evidence of LUTO (i.e. enlarged bladder, bilateral
hydronephrosis, keyhole sign) evaluating antenatal intervention for improving perinatal outcomes.
Any type of intervention was analyzed, including bladder drainage via vesicocentesis, vesico-amniotic
shunt, and fetoscopic surgery, such as fetal cystoscopy, and ablation of valves. Open fetal bladder
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surgery was also included. Uncontrolled observational studies, case reports, and case series were
excluded.
Data extraction and risk of bias assessment
Two reviewers (GS, ER) independently judged the methodological quality of studies included in the
meta-analysis. For non-randomized studies we used a modiﬁed version of the “Newcastle-Oawa
Scale”.8 Quality of studies was evaluated in four diﬀerent domains: “selecon”, “comparability”,
“exposure”, and “outcome”. Review authors’ judgments were categorized as “low risk”, “high risk”
or “unclear risk” of bias.
For randomized trials, the risk of bias was assessed by using the criteria outlined in the Cochrane
Handbook for Systemac Reviews of Intervenons.7 Seven domains related to risk of bias were
assessed in each included trial since there is evidence that these issues are associated with biased
esmates of treatment eﬀect: 1) random sequence generaon; 2) allocaon concealment; 3)
blinding of parcipants and personnel; 4) blinding of outcome assessment; 5) incomplete outcome
data; 6) selecve reporng; and 7) other bias. Review authors’ judgments were categorized as “low
risk”, “high risk” or “unclear risk” of bias.7
Any discrepancies concerning author’s judgements were referred to a third reviewer (AV) and resolved
by consensus.
Outcomes
Primary and secondary outcomes were defined before data extraction. The primary outcome was
perinatal survival. The secondary outcome was postnatal survival with normal renal function.
Outcomes were assessed separately by the type of intervention,
Statistical analysis
The data analysis was completed independently by two authors (GS, AV) using Review Manager
v. 5.3 (The Nordic Cochrane Centre, Cochrane Collaboration, 2014, Copenhagen, Denmark). The
completed analyses were then compared, and any difference was resolved by discussion.
The summary measures were reported as summary odds ratio (OR) with 95% of confidence interval
(CI). The random effects model of DerSimonian and Laird was used due to anticipated heterogeneity
among selected studies. I-squared (Higgins I2) greater than 0% was used to identify heterogeneity.
Data from each eligible study were extracted without modification of original data onto custom-made
data collection forms. A 2 by 2 table was assessed for OR. Data were extracted and imported into
Review Manager. Potential publication biases were assessed statistically by using Begg’s and Egger’s
tests. P value <0.05 was considered statistically significant.
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The meta-analysis was reported following the Preferred Reporng Item for Systemac Reviews and
Meta-analyses (PRISMA) statement.9
RESULTS
Study selection and study characteristics
Selection flow chart is shown in Figure 1. A total of 10 articles with a total of 355 fetuses were included
in the meta-analysis.10-19 Publication bias, assessed using Begg’s and Egger’s tests, was not significant
(P=0.84 and 0.80 respectively), suggesting that all relevant articles have been included. Statistically
heterogeneity within the trials was low with no inconsistency for the primary outcome.
The characteristics of the included studies are summarized in Table 1. Nine studies were controlled
observational studies. Only one study had randomized study design. The interventions were
undertaken between 16 and 28 weeks, in the studies that reported. The overall risk of bias was judged
as low, with most of the included studies having low risk of bias (Figure 2, Figure 3). Regarding the
interventions, the majority were vescico-amniotic shunts.
Inclusion criteria of the selected studies were singleton pregnancy with severe LUTO confirmed on
detailed fetal ultrasound examination, including an extremely dilated bladder with increased wall
thickness (‘megabladder’) associated with a dilated urethra (‘keyhole sign’). Severe LUTO included
PUV in the vast majority of the cases, vescicoureteral reflux, urethral atresia, urethral stenosis,
Prune Belly syndrome, cloacal dysgenesis, cloacal anomaly, megacystis-microcolon syndrome, and
megalourethra. Studies included only pregnancies with no additional fetal malformations. Criteria for
a good predicted prognosis were: Na <100 mEq/l, Cl <90 mEq/l, osmolarity <210 mOsm/l, beta-2-
microglobulin <2 mg/dl.
Synthesis of results
Vescico-amniotic shunt
Nine studies,10-18 conducted between 1990 and 2015, analyzed the efficacy of vescico-amniotic
shunt performed in the second trimester for LUTO. Of the nine included studies, four were
retrospective cohort studies, one was prospective cohort study, one contained combined prospective
and retrospective cohorts, one was a randomized trial, and the other two did not specify the method
of data collection.
Perinatal survival was reported in all the nine selected studies. The overall estimate survival was
higher in the vescico-amniotic shunt group compared to the conservative group (OR 2.54, 95% CI
1.14 to 5.67; Figure 4). We reported 64/112 (57.1%) survived fetuses in the vescico-amniotic shunt
group compared to 52/134 (38.8%) in the control group.
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In subgroup analysis, the vescico-amniotic shunt was associated with higher perinatal survival among
fetuses with non-favorable fetal urinary chemistry, but not among those with favorable fetal urinary
chemistry (Figure 4).
Five studies reported on postnatal renal function between 6 months and 2 years. Good postnatal renal
function was higher in the vescico-amniotic shunt group compared to the conservative group (OR
2.09, 95% CI 0.74 to 5.9; Figure 5).
Vescicocentesis
Six studies reported outcomes of fetuses after vescicocentesis.12-17 However none of them reported
outcomes comparing vescicocentesis with conservative management, thus this intervention could not
be completed in this meta-analysis.
Fetal cystoscopy
Fetal cystoscopy was performed in only two included studies.11,19 Overall, 45 fetuses underwent fetal
cystoscopy. Eleven cases came from Quintero et al. while 34 cases came from Ruano et al. Of the
11 cases reported by Quintero et al. who underwent cystoscopy, 4 received no treatment, 2 received
urethral stent placement, 4 standard vescico-amniotic shunt, and one permeation of PUV. Out of them
34 cases of Ruano et al. 12 of them were noticed PUV at the time of cystoscopy.
The perinatal survival was higher in the cystoscopy group compared to the conservative management
group (OR 2.63, 95% CI 1.07 to 6.47; Figure 6). Long-term follow-up was reported only by Ruano
et al. Normal renal function was noticed in 13/34 fetuses in the cystoscopy group versus 12/61 in the
conservative management group at 6 month follow-up (OR 1.75, 95% CI 1.05 to 2.92)
Open procedure
One study,12 included nine fetuses underwent an open procedure by maternal laparotomy and
hysterotomy, such as open shunt insertion, bladder marsupialization, or cutaneous uterostomy. No
comparison group was provided.
DISCUSSION
Principal findings
This meta-analysis including 10 studies showed that prenatal intervention for congenital LUTO
improves perinatal survival. The vast majority used intervention was vescico-amniotic shunt with
showed to be associated with also long-term beneficial effects, including higher rate of survival with
normal renal function. Data from fetal cystoscopy seems promising but warrants further investigation
as the sample size was small.
This review represents the most comprehensive evidence available on efficacy of antenatal treatment
for LUTO. An extensive literature search was performed in multiple databases, and the robustness of
the methodology is the major strength of the review. This review updated prior review on the topic.1
Morris et al. performed a meta-analysis of all antenatal interventions for congenital LUTO. However,
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they included also uncontrolled studies, and case series, and used different methodology. This review
includes more recent evidence, as well as the only RCT addressing this topic.
Interpretation
Prenatal detection of fetal complications may improve outcomes by optimizing antenatal interventions
and through a better use and better timing of interventions.20-26 Ultrasound technology has high
sensitivity for urologic anomalies, which account for 20% of all prenatally identified congenital
anomalies.27 Congenital LUTO is a group of conditions primarily affecting the male fetus. The most
common cause of LUTO is PUV.27
Vesico-amniotic shunting is a treatment option for relief of the urinary obstruction associated with
severe LUTO but this procedure is associated with complications such as migration, obstruction
and displacement of the shunt tubing.28 An alternative option to vescico-amniotic shunt, is fetal
cystoscopy.29,30 It has the advantage to help determine the etiology of the urophaty, e.g. PUV,
Prune Belly syndrome or urethral atresia. Another potential clinical advantage of fetal cystoscopy
as compared to in-utero vesicoamniotic shunting is avoidance of amnioinfusion, which is often
needed for shunting. Cystoscopy may also allow the placement of a transurethral catheter in case
of urethral stenosis.29 However, fetal cystoscopy is more complex technically and usually requires
special instrumentation and multidisciplinary training at an established center for fetoscopic surgery.
It has been also associated with several complications, including fistulas, fetal bleeding and fetal
demise.30 Findings from this review largely came from vescico-amniotic shunting data. Robust
evidence for other treatments, including fetal cystoscopy, are lacking and therefore clinical utility of
these techniques are still subject of debate due to the small sample size.
Conclusions
In summary, antenatal bladder drainage appears to improve perinatal survival in cases of LUTO.
Randomized trials with long-term follow-up are required to determine the role of antenatal treatment
in clinical setting.JU
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TABLES
Table 1. Characteriscs of the included studies
Study
locaon
Type of the
study
Sample
size*
Type of
intervenon
GA at
intervenon**
Crombleholme
199012
USA Retrospecve
cohort
40 VC, VAS Not reported
Nicolini 199113 UK Not reported 13 VC, VAS 17 - 28
Lipitz 199314 UK Not reported 19 VC, VAS 19 – 25
Johnson 199415 USA Retrospecve
and
prospecve
cohort
22 VC, VAS 14 – 24
Quintero 199519 USA Retrospecve
and
prospecve
cohort
13 Cystoscopy 16-24
Freedman
199616
USA Retrospecve
cohort
52 VC, VAS Not reported
McLorie 200117 Canada Retrospecve
cohort
9 VC, VAS 20 – 28
Morris 201310 UK, Ireland,
and
Netherlands
RCT 31 VAS Not reported
Morris 201518 UK, Ireland,
and
Netherlands
Prospecve
cohort
45 VAS Not reported
Ruano 201511 Brazil and
France
Retrospecve
cohort
111 VAS,
cystoscopy
20.2
*Elecve terminaon of pregnancy was excluded.
**Mean or range in weeks
VAS, vescico-amnioc shunt; RCT, randomized controlled trial; VC, vescicocentesis;
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FIGURES
Figure 1. Flow diagram of studies idenﬁed in the systemac review. (Prisma template [Preferred
Reporng Item for Systemac Reviews and Meta-analyses]).
Figure 2. Assessment of risk of bias for randomized trials. Summary of risk of bias for each trial;
Plus sign: low risk of bias; minus sign: high risk of bias; queson mark: unclear risk of bias.
Figure 3. Modiﬁed Newcastle-Oawa risk of bias scoring judgements for non-randomized studies.
Summary of risk of bias for each study; Plus sign: low risk of bias; minus sign: high risk of bias;
queson mark: unclear risk of bias.
Figure 4. Forest plot for perinatal survival in fetuses with or without vescico-amnioc shunt
Figure 5. Forest plot for good postnatal renal funcon in fetuses with or without vescico-amnioc
shunt
Figure 6. Forest plot for perinatal survival in fetuses with or without fetal cystoscopy
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